Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Tomassini

Showing results (81-90 of 117) with videos related to

Pageof 12
Sort By:
The American Journal of Cardiology|October 21, 2016
Effect on Fasting Serum Glucose Levels of Adding Ezetimibe to Statins in Patients With Nondiabetic HypercholesterolemiaPeter P Toth, Alberico L Catapano, Michel Farnier, et al.
Journal of Clinical Lipidology|October 21, 2019
Comparing remnant lipoprotein cholesterol measurement methods to evaluate efficacy of ezetimibe/statin vs statin therapyPeter P Toth, Harold E Bays, W Virgil Brown, et al.
Journal of Natural Products|August 24, 2002
Durhamycin A, a potent inhibitor of HIV Tat transactivationHiranthi Jayasuriya, Russell B Lingham, Pia Graham, et al.
The American Journal of Cardiology|June 23, 2009
Lipid-altering efficacy and safety of ezetimibe/simvastatin versus atorvastatin in patients with hypercholesterolemia and the metabolic syndrome (from the VYMET study)Jennifer G Robinson, Christie M Ballantyne, Scott M Grundy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2017
PD-L2 Expression in Human Tumors: Relevance to Anti-PD-1 Therapy in CancerJennifer H Yearley, Christopher Gibson, Ni Yu, et al.
Nature Medicine|December 10, 2021
A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virusAllison August, Husain Z Attarwala, Sunny Himansu, et al.
Nature Medicine|April 22, 2022
Author Correction: A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virusAllison August, Husain Z Attarwala, Sunny Himansu, et al.
Journal of Clinical Lipidology|October 2, 2013
Treatment pattern changes in high-risk patients newly initiated on statin monotherapy in a managed care settingRoss J Simpson, Kaan Tunceli, Dena R Ramey, et al.
Journal of Medicinal Chemistry|February 18, 2005
Synthesis and evaluation of S-acyl-2-thioethyl esters of modified nucleoside 5'-monophosphates as inhibitors of hepatitis C virus RNA replicationThazha P Prakash, Marija Prhavc, Anne B Eldrup, et al.
Bioorganic & Medicinal Chemistry|November 3, 2004
Synthesis and biological evaluation of 5R- and 5S-methyl substituted D- and L-configuration 1,3-dioxolane nucleoside analogsSanjib Bera, Leila Malik, Balkrishen Bhat, et al.
Pageof 12

Showing results (81-90 of 117) with videos related to

Sort By:
Pageof 12
The American Journal of Cardiology|October 21, 2016
Effect on Fasting Serum Glucose Levels of Adding Ezetimibe to Statins in Patients With Nondiabetic HypercholesterolemiaPeter P Toth, Alberico L Catapano, Michel Farnier, et al.
Journal of Clinical Lipidology|October 21, 2019
Comparing remnant lipoprotein cholesterol measurement methods to evaluate efficacy of ezetimibe/statin vs statin therapyPeter P Toth, Harold E Bays, W Virgil Brown, et al.
Journal of Natural Products|August 24, 2002
Durhamycin A, a potent inhibitor of HIV Tat transactivationHiranthi Jayasuriya, Russell B Lingham, Pia Graham, et al.
The American Journal of Cardiology|June 23, 2009
Lipid-altering efficacy and safety of ezetimibe/simvastatin versus atorvastatin in patients with hypercholesterolemia and the metabolic syndrome (from the VYMET study)Jennifer G Robinson, Christie M Ballantyne, Scott M Grundy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2017
PD-L2 Expression in Human Tumors: Relevance to Anti-PD-1 Therapy in CancerJennifer H Yearley, Christopher Gibson, Ni Yu, et al.
Nature Medicine|December 10, 2021
A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virusAllison August, Husain Z Attarwala, Sunny Himansu, et al.
Nature Medicine|April 22, 2022
Author Correction: A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virusAllison August, Husain Z Attarwala, Sunny Himansu, et al.
Journal of Clinical Lipidology|October 2, 2013
Treatment pattern changes in high-risk patients newly initiated on statin monotherapy in a managed care settingRoss J Simpson, Kaan Tunceli, Dena R Ramey, et al.
Journal of Medicinal Chemistry|February 18, 2005
Synthesis and evaluation of S-acyl-2-thioethyl esters of modified nucleoside 5'-monophosphates as inhibitors of hepatitis C virus RNA replicationThazha P Prakash, Marija Prhavc, Anne B Eldrup, et al.
Bioorganic & Medicinal Chemistry|November 3, 2004
Synthesis and biological evaluation of 5R- and 5S-methyl substituted D- and L-configuration 1,3-dioxolane nucleoside analogsSanjib Bera, Leila Malik, Balkrishen Bhat, et al.
Pageof 12